NEI

KEI Comments Regarding NIH Exclusive License on Gene Therapy to Treat Ocular Disease

Posted on by KEI Staff

On Friday January 10, 2020, Knowledge Ecology International (KEI) submitted comments to the National Institutes of Health (NIH) regarding the “Prospective Grant of an Exclusive Patent License: Gene Therapy for Ocular Disease” to OcQuila Therapeutics, Ltd. (84 FR 65169). The… Continue Reading →

KEI Comments to the NIH on Exclusive License to Opsis Therapeutics for Retinal Cell Therapies

Posted on by Claire Cassedy

On October 18, 2019, Knowledge Ecology International (KEI) submitted comments to the Federal Register Notice for the “Prospective Grant of an Exclusive Patent License: Compositions, Devices and Processes for Production and Delivery of Cell Grafts of Manufactured Retinal Pigment Epithelium… Continue Reading →